Neuroendovascular coil market seen reaching $1.96 billion by 2030

The Business Research Company says the global neuroendovascular coil market will grow from $1.39 billion in 2025 to $1.49 billion in 2026, then reach $1.96 billion by 2030. Demand is being lifted by rising neurovascular disease cases, higher healthcare spending and broader adoption of minimally invasive aneurysm treatments.

Why it matters: - The neuroendovascular coil market sits at the center of treatment for cerebral aneurysms and other neurovascular disorders. - Growth in this market reflects rising demand for minimally invasive procedures that can reduce bleeding risk and support safer aneurysm management. - The market outlook also points to broader investment in stroke care, neurointerventional capacity and next-generation embolization devices.

What happened: - The Business Research Company published a 2026 report on the global neuroendovascular coil market. - The report puts market value at $1.39 billion in 2025 and $1.49 billion in 2026. - The report forecasts the market will reach $1.96 billion by 2030. - The forecast implies a 7.1% CAGR from 2025 to 2026 and a 7.0% CAGR through 2030. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company also published a free sample of the report and a full market report.

The details: - A neuroendovascular coil is a delicate wire inserted into blood vessels to obstruct or redirect blood flow and encourage clot formation. - The devices are primarily used to treat cerebral aneurysms and other vascular abnormalities. - The report identifies rising cerebral aneurysm cases, advances in endovascular treatment, more neurointerventional procedures, more stroke treatment facilities and stronger clinical expertise as past growth drivers. - The report points to next-generation embolization devices, more funding for neurovascular research, expansion of minimally invasive therapies, safer aneurysm management and personalized neurointerventional treatments as future drivers. - The report highlights wider use of advanced detachable coil designs, greater use of flow-diverter and matrix coils, refined deployment techniques and a focus on long-term outcomes as major trends. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period.

Between the lines: - The market growth story is being shaped by two forces at once: more patients with neurovascular disease and more spending on the tools and facilities used to treat them. - An aging population is increasing the burden of stroke and aneurysm care, which raises demand for coil-based interventions. - The report's regional split suggests mature demand in North America and faster expansion in markets building out healthcare access and infrastructure. - In March 2025, the Stroke Association said the UK had 1.3 million stroke survivors in 2024 and projected that number would rise to 2.1 million by 2035. - Health Affairs reported in June 2024 that U.S. national healthcare expenditure is projected to rise from $4,799.3 billion in 2023 to $5,048.8 billion in 2024.

What's next: - The market is expected to keep expanding as hospitals and specialists adopt newer coil technologies and less invasive procedures. - Future gains will likely depend on continued research spending, broader access to neurovascular care and better outcomes from updated coil designs. - The company says its latest 2026 reports add market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, hotspot infographics and updated graphics. - For more information, the company lists contact details for Saumya Sahay at marketing@tbrc.info and through its website and social channels.

The bottom line: - Neuroendovascular coils are moving from a specialized device category toward a larger, faster-growing market tied to rising stroke and aneurysm treatment needs.